R&D Clinical research demands agile CROs An emerging consensus across sponsors, investigators, and regulators is that agility must become a defining attribute of CRO performance.
Digital The imperative of agility in UK healthcare cybersecurity In an era where cyber threats are becoming increasingly sophisticated, the necessity for agile and constantly updated cybersecurity arrangements in the UK's healthcare system cannot be over
R&D Sponsored Embracing new delivery models in the UK The clinical research landscape in the UK is on the cusp of a major transformation.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
